Macrolide resistance in adults with bacteremic pneumococcal pneumonia

Emerging Infectious Diseases

Volumn 12, Issue 8, 2006, Pages 1223-1230

  Metlay, Joshua P ^a,b,c   Fishman, Neil O ^b   Joffe, Marshall M ^b   Kallan, Michael J ^b   Chittams, Jesse L ^b   Edelstein, Paul H ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c Center for Clinical Epidemiology and Biostatistics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; MACROLIDE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; CASE CONTROL STUDY; DRUG EFFECT; FEMALE; HEALTH SURVEY; HOSPITALIZATION; HUMAN; INTERVIEW; LOBAR PNEUMONIA; MALE; MICROBIOLOGY; MIDDLE AGED; RISK FACTOR; STREPTOCOCCUS PNEUMONIAE; UNITED STATES;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; CASE-CONTROL STUDIES; DRUG RESISTANCE, BACTERIAL; FEMALE; HOSPITALIZATION; HUMANS; INTERVIEWS; MACROLIDES; MALE; MIDDLE AGED; PENNSYLVANIA; PNEUMONIA, PNEUMOCOCCAL; POPULATION SURVEILLANCE; RISK FACTORS; STREPTOCOCCUS PNEUMONIAE;

EID: 33750604330     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1708.060017     Document Type: Article

References (31)

1. Plouffe JF, Breiman RF, Facklam RR. Bacteremia with Streptococcus pneumoniae. Implications for therapy and prevention. Franklin County Pneumonia Study Group. JAMA. 1996;275:194-8.
2. Metlay JP. Antibacterial drug resistance: implications for the treatment of patients with community-acquired pneumonia. Infect Dis Clin North Am. 2004;18:777-90.
3. Whitney CG, Farley MM, Hadler J, Harrison LH, Lexau C, Reingold A, et al. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N Engl J Med. 2000;343:1917-24.
4. Karlowsky JA, Thornsberry C, Jones ME, Evangelista AT, Critchley IA, Sahm DF. Factors associated with relative rates of antimicrobial resistance among Streptococcus pneumoniae in the United States: results from the TRUST Surveillance Program (1998-2002). Clin Infect Dis. 2003;36:963-70.
5. MacDougall C, Guglielmo BJ, Maselli J, Gonzales R. Antimicrobial drug prescribing for pneumonia in ambulatory care. Emerg Infect Dis. 2005;11:380-4.
6. Lonks JR, Garau J, Gomez L, Xercavins M, Ochoa de Echaguen A, Gareen IF, et al. Failure of macrolide antibiotic treatment in patients with bacteremia due to erythromycin-resistant Streptococcus pneumoniae. Clin Infect Dis. 2002;35:556-64.
7. Mandell LA, Bartlett JG, Dowell SF, File TM Jr, Musher DM, Whitney C. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis. 2003;37:1405-33.
8. Mitchell AA, Cottler LB, Shapiro S. Effect of questionnaire design on recall of drug exposure in pregnancy. Am J Epidemiol. 1986;123:670-6.
9. Coulter A, Vessey M, McPherson K, Crossley B. The ability of women to recall their oral contraceptive histories. Contraception. 1986;33:127-37.
10. Beresford SA, Coker AL. Pictorially assisted recall of past hormone use in case-control studies. Am J Epidemiol. 1989;130:202-5.
11. Metlay JP, Hardy C, Strom BL. Agreement between patient self-report and a Veterans Affairs national pharmacy database for identifying recent exposures to antibiotics. Pharmacoepidemiol Drug Saf. 2003;12:9-15.
12. Koneman E, Allen S, Janda W, Schreckenberger P, Winn W Jr. Color atlas and textbook of diagnostic microbiology. 5th ed. Philadelphia: Lippincott-Raven; 1997.
13. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. 15th information supplement. Wayne (PA): The Committee; 2005.
14. Etest technical manual. Etest application sheet. Streptococcus pneumoniae. 2005 [cited 2006 May 29]. http://www.abbiodisk.com/pdf/etm- index.htm
15. Austrian R. The quellung reaction, a neglected microbiologic technique. Mt Sinai J Med. 1976;43:699-709.
16. Sorensen UB. Typing of pneumococci by using 12 pooled antisera. J Clin Microbiol. 1993;31:2097-100.
17. Pneumotest manual. Copenhagen: Statens Serum Institut; 2001.
18. Edelstein PH. Pneumococcal resistance to macrolides, lincosamides, ketolides, and streptogramin B agents: molecular mechanisms and resistance phenotypes. Clin Infect Dis. 2004;38(Suppl 4):S322-7.
19. Friedland IR. Comparison of the response to antimicrobial therapy of penicillin- resistant and penicillin-susceptible pneumococcal disease. Pediatr Infect Dis J. 1995;14:885-90.
20. Kronenberger CB, Hoffman R, Lezotte D, Marine W. Invasive penicillin-resistant pneumococcal infections: a prevalence and historical cohort study. Emerg Infect Dis. 1996;2:121-4.
21. Moreno S, Garcia-Leoni ME, Cercenado E, Diaz MD, Bernaldo de Quiros JC, Bouza E. Infections caused by erythromycin-resistant Streptococcus pneumoniae: incidence, risk factors, and response to therapy in a prospective study. Clin Infect Dis. 1995;20:1195-200.
22. Nava JM, Bella F, Garau J, Lite J, Morera MA, Marti C, et al. Predictive factors for invasive disease due to penicillin-resistant Streptococcus pneumoniae: a population-based study. Clin Infect Dis. 1994;19:884-90.
23. Pallares R, Gudiol F, Linares J, Ariza J, Rufi G, Murgui L, et al. Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci. N Engl J Med. 1987;317:18-22.
24. Tan TQ, Mason EO Jr, Kaplan SL. Penicillin-resistant systemic pneumococcal infections in children: a retrospective case-control study. Pediatrics. 1993;92:761-7.
25. Ruhe JJ, Hasbun R. Streptococcus pneumoniae bacteremia: duration of previous antibiotic use and association with penicillin resistance. Clin Infect Dis. 2003;36:1132-8.
26. Vanderkooi OG, Low DE, Green K, Powis JE, McGeer A. Predicting antimicrobial resistance in invasive pneumococcal infections. Clin Infect Dis. 2005;40:1288-97.
27. Campbell GD Jr, Silberman R. Drug-resistant Streptococcus pneumoniae. Clin Infect Dis. 1998;26:1188-95.
28. Klugman KP. Pneumococcal resistance to antibiotics. Clin Microbiol Rev. 1990;3:171-96.
29. Reichler MR, Allphin AA, Breiman RF, Schreiber JR, Arnold JE, McDougal LK, et al. The spread of multiply resistant Streptococcus pneumoniae at a day care center in Ohio. J Infect Dis. 1992;166:1346-53.
30. Mainous AG III, Cheng AY, Garr RC, Tilley BC, Everett CJ, McKee MD. Nonprescribed antimicrobial drugs in Latino community, South Carolina. Emerg Infect Dis. 2005;11:883-8.
31. Harris AD, Karchmer TB, Carmeli Y, Samore MH. Methodological principles of case-control studies that analyzed risk factors for antibiotic resistance: a systematic review. Clin Infect Dis. 2001;32:1055-61.